- Website
- vintabio.com
- Total Funding
- $64.0M
- Last Round
- $64.0M Series CApr 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
VintaBio is a Biotech company. It has raised $64.0M in total across 1 round, most recently a $64.0M Series C round in Apr 2023. Investors include Decheng Capital.
Funding History
Apr 2023
Investors
Similar Companies

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vintabio"><img src="https://indexed.vc/api/badge/company/vintabio" alt="VintaBio on Indexed.vc" width="260" height="76" /></a>
